BRPI0114927B8 - composição de gel farmacêutica não aquosa para aplicação na pele, e, uso de uma composição - Google Patents

composição de gel farmacêutica não aquosa para aplicação na pele, e, uso de uma composição

Info

Publication number
BRPI0114927B8
BRPI0114927B8 BRPI0114927A BR0114927A BRPI0114927B8 BR PI0114927 B8 BRPI0114927 B8 BR PI0114927B8 BR PI0114927 A BRPI0114927 A BR PI0114927A BR 0114927 A BR0114927 A BR 0114927A BR PI0114927 B8 BRPI0114927 B8 BR PI0114927B8
Authority
BR
Brazil
Prior art keywords
composition
skin
application
pharmaceutical gel
aqueous pharmaceutical
Prior art date
Application number
BRPI0114927A
Other languages
English (en)
Other versions
BR0114927B1 (pt
BR0114927A (pt
Inventor
Johannes Didriksen Erik
Høy Gert
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0114927(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of BR0114927A publication Critical patent/BR0114927A/pt
Publication of BR0114927B1 publication Critical patent/BR0114927B1/pt
Publication of BRPI0114927B8 publication Critical patent/BRPI0114927B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Abstract

"composição de gel farmacêutica substancialmente não aquosa para aplicação na pele, e, uso da composição". a presente invenção diz respeito a uma composição farmacêutica em gel para aplicação na pele, a dita composição compreendendo pelo menos uma vitamina d ou análogo de vitamina d e pelo menos um corticosteróide bem como um excipiente que aumenta a viscosidade.
BRPI0114927A 2000-10-27 2001-09-26 composição de gel farmacêutica não aquosa para aplicação na pele, e, uso de uma composição BRPI0114927B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24347100P 2000-10-27 2000-10-27
PCT/DK2001/000613 WO2002034235A1 (en) 2000-10-27 2001-09-26 Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid

Publications (3)

Publication Number Publication Date
BR0114927A BR0114927A (pt) 2003-12-23
BR0114927B1 BR0114927B1 (pt) 2017-12-05
BRPI0114927B8 true BRPI0114927B8 (pt) 2021-05-25

Family

ID=22918889

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0114927A BRPI0114927B8 (pt) 2000-10-27 2001-09-26 composição de gel farmacêutica não aquosa para aplicação na pele, e, uso de uma composição

Country Status (22)

Country Link
US (1) US6787529B2 (pt)
EP (1) EP1331927B1 (pt)
JP (3) JP4451061B2 (pt)
KR (1) KR100844285B1 (pt)
CN (1) CN100382803C (pt)
AT (1) ATE380542T1 (pt)
AU (2) AU2001291637B2 (pt)
BR (1) BRPI0114927B8 (pt)
CA (1) CA2423930C (pt)
CY (1) CY1107294T1 (pt)
CZ (1) CZ305984B6 (pt)
DE (1) DE60131881T2 (pt)
DK (1) DK1331927T3 (pt)
ES (1) ES2298264T3 (pt)
HK (1) HK1077208A1 (pt)
HU (1) HU230005B1 (pt)
IL (2) IL154888A0 (pt)
MX (1) MXPA03003511A (pt)
PL (1) PL212660B1 (pt)
PT (1) PT1331927E (pt)
RU (1) RU2271810C2 (pt)
WO (1) WO2002034235A1 (pt)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
ES2298264T3 (es) * 2000-10-27 2008-05-16 Leo Pharma A/S Composicion topica que contiene al menos una vitamina d o un analogo de vitamina d y al menos un corticoesteroide.
US20090143328A1 (en) * 2001-08-13 2009-06-04 Mcdonald George Method of Treating Cancer by Administration of Topical Active Corticosteroids
MXPA05003805A (es) * 2002-12-17 2005-06-08 Galderma Sa Composiciones farmaceuticas que comprenden una combinacion de calcitriol y propionato de clobetasol.
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
FR2871694B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises
FR2871698B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
FR2871693B1 (fr) * 2004-06-17 2006-08-25 Galderma Sa Utilisation d'une composition pharmaceutique comprenant du calcitriol et du propionate de clobetasol pour le traitement du psoriasis
FR2871697B1 (fr) * 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
FR2871700B1 (fr) * 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
EP1781302A4 (en) * 2004-07-28 2010-02-17 Lipopeptide Ab NEW USE
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
DK1879595T3 (en) * 2005-05-10 2015-01-05 Dermipsor Ltd Preparations and Methods for the Treatment of Hyperproliferative Epidermal Diseases
NZ563560A (en) 2005-06-01 2009-11-27 Stiefel Res Australia Pty Ltd Vitamin formulation for treating a dermatological skin disorder
WO2006131401A2 (en) * 2005-06-10 2006-12-14 Galderma S.A. Controlled release of a drug through skin on the basis of a topical composition comprising a drug, a film-forming silicone and at least one volatile solvent
MXPA05009381A (es) * 2005-09-02 2007-03-01 Fernando Ahumada Ayala Preparaciones para el cuidado de la piel que contienen mupirocina y dipropionato de betametasona.
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
EP1844010B1 (en) 2006-03-17 2013-02-13 Leo Pharma A/S Isomerisation of pharmaceutical intermediates
KR20090039833A (ko) * 2006-08-29 2009-04-22 테바 파마슈티컬 인더스트리즈 리미티드 비타민 ｄ 및 코르티코스테로이드를 포함하는 약학 조성물
FR2909284B1 (fr) * 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
ES2272198B1 (es) * 2006-12-28 2008-06-01 Laboratorios Viñas S.A. Procedimiento para la obtencion de hidrato de calcipotriol.
EP1970048A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D
EP1970049A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D and corticosteroid
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
US8865692B2 (en) 2007-11-13 2014-10-21 Meritage Pharma, Inc Compositions for the treatment of gastrointestinal inflammation
CA2704957A1 (en) 2007-11-13 2009-05-22 Meritage Pharma, Inc. Compositions for the treatment of gastrointestinal inflammation
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
US9254296B2 (en) * 2009-12-22 2016-02-09 Leo Pharma A/S Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture
US20130039952A1 (en) * 2009-12-22 2013-02-14 Leo Pharma A/S Calcipotriol monohydrate nanocrystals
AU2010335654B2 (en) * 2009-12-22 2015-04-09 Leo Pharma A/S Cutaneous composition comprising vitamin D analogue and a mixture of solvent and surfactants
PL2579852T3 (pl) 2010-06-11 2015-04-30 Leo Pharma As Farmaceutyczna kompozycja sprayu zawierająca analog witaminy D i kortykosteroid
US8968755B2 (en) 2010-10-23 2015-03-03 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US8685381B2 (en) * 2010-10-23 2014-04-01 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
PT2686017T (pt) 2011-03-14 2019-10-24 Drug Delivery Solutions Ltd Uma composição oftálmica.
JP5897299B2 (ja) * 2011-10-14 2016-03-30 岩城製薬株式会社 ローション剤
CN104138352B (zh) * 2013-04-19 2018-02-27 江苏知原药业有限公司 卡泊三醇非水凝胶
TW201636025A (zh) * 2015-04-15 2016-10-16 Maruho Kk 皮膚用之醫藥組成物
JP6997624B2 (ja) * 2015-06-18 2022-01-17 ボシュ ヘルス ユーエス，エルエルシー． 乾癬を治療するためのコルチコステロイドおよびレチノイドを含む局所用組成物
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
KR102354028B1 (ko) 2020-05-13 2022-01-24 동국대학교 경주캠퍼스 산학협력단 건선 예방, 개선 또는 치료용 피부 외용제 조성물
CN114159567B (zh) * 2020-09-10 2023-03-31 南京海融医药科技股份有限公司 一种治疗皮肤病的混悬凝胶剂
CN115569199A (zh) * 2022-02-14 2023-01-06 南京海融医药科技股份有限公司 一种药物组合物及其制备方法和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569935A (en) * 1983-03-17 1986-02-11 University Of Tennessee Research Corp. Topical treatment of psoriasis with imidazole antibiotics
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
SE457055B (sv) * 1986-08-18 1988-11-28 Ferring Ab Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser
IL86170A (en) * 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
US4847071A (en) 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
US5002938A (en) * 1988-03-21 1991-03-26 Bristol-Myers Squibb Company Antifungal gel formulations
DK0437225T3 (da) * 1990-01-10 1994-06-27 Hoffmann La Roche Topiske præparater
US5185150A (en) * 1990-08-24 1993-02-09 Wisconsin Alumni Research Fdn. Cosmetic compositions containing 19-nor-vitamin D compounds
US5763428A (en) * 1990-09-21 1998-06-09 Bone Care International, Inc. Methods of treating skin disorders with novel 1a-hydroxy vitamin D4 compounds and derivatives thereof
JP2571493B2 (ja) * 1992-06-04 1997-01-16 株式会社資生堂 皮膚外用剤
DK0614456T3 (da) * 1992-08-28 1999-12-06 Bone Care Int Inc 1alfa,24(S)-dihydroxy-vitamin D2, dets fremstilling og anvendelse
GB9226860D0 (en) * 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Novel treatment
DE4328217C2 (de) * 1993-08-21 1996-01-11 Lohmann Therapie Syst Lts Therapeutisches System zur Behandlung der Psoriasis
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
FR2740042B1 (fr) * 1995-10-23 1997-11-14 Oreal Support, et composition contenant ce support et un actif cosmetique ou dermatologique stabilise
JPH10158147A (ja) * 1996-11-29 1998-06-16 Kenji Nakamura 皮膚保護用の被膜組成物とそれを用いた製品
DE59712694D1 (de) * 1997-04-18 2006-08-24 Fritz Stanislaus Stabilisiertes arzneimittel enthaltend cysteinylderivate
JPH11188054A (ja) * 1997-12-25 1999-07-13 Lion Corp 皮膚外用部材
US5990100A (en) 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
FR2785284B1 (fr) * 1998-11-02 2000-12-01 Galderma Res & Dev Analogues de la vitamine d
NZ515142A (en) * 1999-04-23 2004-01-30 Leo Pharm Prod Ltd Pharmaceutical composition
ES2298264T3 (es) * 2000-10-27 2008-05-16 Leo Pharma A/S Composicion topica que contiene al menos una vitamina d o un analogo de vitamina d y al menos un corticoesteroide.

Also Published As

Publication number Publication date
JP4451061B2 (ja) 2010-04-14
CN1633280A (zh) 2005-06-29
CZ305984B6 (cs) 2016-06-08
EP1331927B1 (en) 2007-12-12
WO2002034235A1 (en) 2002-05-02
CN100382803C (zh) 2008-04-23
PL360941A1 (en) 2004-09-20
BR0114927B1 (pt) 2017-12-05
JP2004512297A (ja) 2004-04-22
CY1107294T1 (el) 2012-11-21
BR0114927A (pt) 2003-12-23
JP5721927B2 (ja) 2015-05-20
KR20030048083A (ko) 2003-06-18
HK1077208A1 (en) 2006-02-10
HUP0302881A2 (hu) 2003-12-29
AU2001291637B2 (en) 2006-04-06
KR100844285B1 (ko) 2008-07-09
ATE380542T1 (de) 2007-12-15
AU9163701A (en) 2002-05-06
US20020111336A1 (en) 2002-08-15
IL154888A0 (en) 2003-10-31
US6787529B2 (en) 2004-09-07
PL212660B1 (pl) 2012-11-30
RU2271810C2 (ru) 2006-03-20
JP5699169B2 (ja) 2015-04-08
EP1331927A1 (en) 2003-08-06
JP2013075924A (ja) 2013-04-25
ES2298264T3 (es) 2008-05-16
DE60131881T2 (de) 2008-12-04
HUP0302881A3 (en) 2012-03-28
CA2423930A1 (en) 2002-05-02
IL154888A (en) 2013-12-31
JP2008297310A (ja) 2008-12-11
PT1331927E (pt) 2008-01-30
HU230005B1 (en) 2015-04-28
MXPA03003511A (es) 2004-05-04
CA2423930C (en) 2009-11-24
DK1331927T3 (da) 2008-05-05
DE60131881D1 (de) 2008-01-24

Similar Documents

Publication Publication Date Title
BRPI0114927B8 (pt) composição de gel farmacêutica não aquosa para aplicação na pele, e, uso de uma composição
BRPI0410503A (pt) uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição
BR0207726A (pt) Sais farmacêuticos
BRPI0412815A (pt) extrato de plantas com eficácia prebiótica
BRPI0612669B8 (pt) composição imunogênica, vacina, composição, e composição liofilizada
BRPI0009956A (pt) composição farmacêutica não aquosa para uso dermatológico compreendendo calcipotriol e betametasona, e, uso da mesma
SV2001000004A (es) Difenil ureas w-carboxyaril sustituidas, composición farmacéutica que las comprende y su uso como inhibidores de raf quinasa
BRPI0517500A (pt) compostos, uso de uma composição, composição farmacêutica, composição cosmética, uso não-terapêutico de uma composição cosmética e processo cosmético para melhorar a aparência da pele
HN2002000319A (es) Benzamida, heteroarilamida y amidas inversas
BRPI0511209A (pt) composição farmacêutica e uso de uma associação de propionato de clobetasol e de calcitriol
ES2169147T3 (es) Derivados de beta-carbolina agonistas de la melatonina, sus procedimientos de preparacion y su utilizacion a titulo de medicamento.
ECSP034883A (es) Amidas de acidos antranilicos con cadena lateral de heteroarilsulfonilo, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como preparados farmaceuticos que las contienen
BRPI0609765A8 (pt) mistura de isoalcano, método para a preparação da mesma, composição cosmética ou farmacêutica, e, uso de uma mistura de isoalcano
BRPI0415713A (pt) mio-inositol hexafosfato para uso tópico
BR9702074A (pt) Compostos biaril heterocíclicos composições farmacêuticas e cosméticas que os contêm e suas utilizações
ES2187125T3 (es) Compuestos biciclicos-aromaticos y su utilizacion en medicina humana o veterinaria asi como en cosmetologia.
AR030140A1 (es) Composiciones derivadas de la 2-piridinamina y metodos relacionados
BRPI0607976A2 (pt) composição farmacêutica e uso de uma composição
BRPI0416188A (pt) formulações de medicamentos que contêm aromatizante, com propriedades farmacêuticas aperfeiçoadas
BRPI0611526A2 (pt) composição tópica contendo gelatina
SV2001000253A (es) Pirazolo (4,3-e) diazepinas sustituidas novedosas, composiciones farmaceuticas que las contienen, su uso como productos medicinales y procesos para prepararlas
BR0210063A (pt) Composição estável e uso da mesma
ATE405276T1 (de) Pharmazeutische gel-zusammensetzung
SV2002000626A (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso ref. lea 34750-sv
BR0309786A (pt) Compostos, seu uso, composição farmacêutica, composição cosmética e uso cosmético de uma composição

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/09/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 26/09/2021